Results 61 to 70 of about 36,570 (229)
Variceal hemorrhage is a complication of portal hypertension that has high mortality and high recurrence rates. Management of variceal bleeding involves three areas: treatment of active hemorrhage, prevention of rebleeding, and prevention of first variceal bleeding.
V J, Navarro, G, Garcia-Tsao
openaire +2 more sources
Noninvasive parameters for assessment of esophageal varices
Objective This study aims to assess esophageal varices (EV) by noninvasive parameters in patients with liver cirrhosis. Background The current guidelines recommend the screening of all cirrhotic patients by endoscopy for EV, but repeated endoscopic ...
Ehab A.A Elatty +4 more
doaj +1 more source
In the POISE open‐label extension, patients with primary biliary cholangitis with inadequate response or intolerance to ursodeoxycholic acid received long‐term obeticholic acid (OCA) treatment. Findings demonstrated a safety profile consistent with the known characteristics of OCA, with no unexpected safety signals, while supporting sustained efficacy ...
Christopher L. Bowlus +8 more
wiley +1 more source
Background & Objective Few trials have compared the efficacy of intravenous (IV) iron repletion to oral repletion for patients with gastrointestinal bleeding (GIB).
Mohamed Abuelazm +7 more
doaj +1 more source
Doppler assessment of hepatic venous waves for predicting large varices in cirrhotic patients
Background/Aim: Color Doppler examination of changes in hepatic venous waveforms is being evaluated as a means of prediction of severity of portal hypertension and presence of esophageal varices.
Thomas Joseph +3 more
doaj +1 more source
Variceal Bleeding Prophylaxis: Variceal Banding or Propranolol [PDF]
Background and Methods: We compared propranolol therapy and endoscopic ligation for the primary prevention of bleeding from esophageal varices. This prospective, controlled trial included consecutive eligible patients who had large varices (> 5mm in diameter) that were at high risk for bleeding. The patients were assigned to either propranolol therapy,
openaire +2 more sources
A metaanalysis of 34 studies/37 cohorts using the Siemens Healthineers ELF test for biopsy‐staged F2, F3, or F4 MASLD‐associated fibrosis validates 9.0 (≥F2), 9.8 (≥F3), and 11.3 (F4) cut‐offs, and establishes 10.5 as a high‐specificity F4 cut‐off. This potentially holds implications for guideline revisions and aiding qualification for antifibrotic ...
Matthew F. W. Gee +6 more
wiley +1 more source
Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala +13 more
wiley +1 more source
Metabolic dysfunction‐associated steatohepatitis is the second commonest US indication for liver transplantation but remains largely undiagnosed and untreated. Fibrosis stage is the strongest predictor of major adverse liver outcomes, with decompensation rates and transplant‐free survival diverging sharply between F3 and F4, while cardiovascular ...
Malek Ayoub +2 more
wiley +1 more source
Summary Background Same‐site recurrence at the sapheno‐femoral junction (SFJ) takes up a large amount of the daily practice of phlebologists. Follow‐up data for high‐ligation and stripping (HL/S) of the great saphenous vein (GSV) are quite heterogenous and incoherent.
Thomas Hummel +11 more
wiley +1 more source

